ATE143801T1 - Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben - Google Patents

Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben

Info

Publication number: ATE143801T1
Authority: AT; Austria
Prior art keywords: active substance; composition; pct; producing; same
Prior art date: 1992-07-03

Application number

AT93916292T

Other languages

English (en)

Inventor

Arie Cornelis Besemer

Coenraad Ferdinand Lerk

Original Assignee

Tno

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-03

Filing date

1993-07-02

Publication date

1996-10-15

1993-07-02 Application filed by Tno filed Critical Tno

1996-10-15 Application granted granted Critical

1996-10-15 Publication of ATE143801T1 publication Critical patent/ATE143801T1/de

Links

239000013543 active substance Substances 0.000 title abstract 6
238000004519 manufacturing process Methods 0.000 title 1
229920000310 Alpha glucan Polymers 0.000 abstract 1
229920000856 Amylose Polymers 0.000 abstract 1
229920001503 Glucan Polymers 0.000 abstract 1
GUBGYTABKSRVRQ-ASMJPISFSA-N alpha-maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-ASMJPISFSA-N 0.000 abstract 1
230000003111 delayed effect Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
229920001282 polysaccharide Polymers 0.000 abstract 1
239000005017 polysaccharide Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT93916292T 1992-07-03 1993-07-02 Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben ATE143801T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NL9201195A NL9201195A (nl)	1992-07-03	1992-07-03	Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.

Publications (1)

Publication Number	Publication Date
ATE143801T1 true ATE143801T1 (de)	1996-10-15

Family

ID=19861014

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93916292T ATE143801T1 (de)	1992-07-03	1993-07-02	Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben

Country Status (12)

Country	Link
US (1)	US5585114A (de)
EP (1)	EP0648116B1 (de)
JP (1)	JPH07508533A (de)
AT (1)	ATE143801T1 (de)
AU (1)	AU678166B2 (de)
CA (1)	CA2139494A1 (de)
DE (1)	DE69305346T2 (de)
DK (1)	DK0648116T3 (de)
ES (1)	ES2095658T3 (de)
GR (1)	GR3022195T3 (de)
NL (1)	NL9201195A (de)
WO (1)	WO1994001092A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL9401572A (nl) *	1994-09-27	1996-05-01	Avebe Coop Verkoop Prod	Zetmeelprodukten als tabletteerhulpstof, werkwijze voor het bereiden daarvan alsmede werkwijze voor het maken van tabletten.
FR2743496B1 (fr) *	1996-01-15	1998-04-10	Univ Rennes	Composite macroporeux support de substance(s) medicamenteuse(s) utilisable comme materiau de reconstitution osseuse et procede d'elaboration
GB9605857D0 (en) *	1996-03-20	1996-05-22	Tester Richard F	Polysaccharides as chemical release systems
US5879707A (en) *	1996-10-30	1999-03-09	Universite De Montreal	Substituted amylose as a matrix for sustained drug release
CA2211778A1 (en) *	1997-08-14	1999-02-14	Francois Carriere	Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents
WO1999030691A2 (en) *	1997-12-18	1999-06-24	Ato B.V.	Composition for the controlled release of active compounds
EA008224B1 (ru)	2001-03-13	2007-04-27	Пенвест Фармасьютикалз Ко.	Хронотерапевтические дозированные формы
JP3742335B2 (ja) *	2001-12-20	2006-02-01	富士通株式会社	入出力バッファ回路
US7081261B2 (en) *	2002-05-14	2006-07-25	National Starch And Chemical Investment Holding Corporation	Resistant starch prepared by isoamylase debranching of low amylose starch
US6890571B2 (en) *	2002-05-14	2005-05-10	National Starch And Chemical Investment Holding Corporation	Slowly digestible starch product
US6929817B2 (en) *	2002-05-14	2005-08-16	National Starch & Chemical Investment Holding Corporation	Slowly digestible starch product
US20040185097A1 (en) *	2003-01-31	2004-09-23	Glenmark Pharmaceuticals Ltd.	Controlled release modifying complex and pharmaceutical compositions thereof
JP4959191B2 (ja)	2003-07-11	2012-06-20	旭化成ケミカルズ株式会社	機能性澱粉粉末
US20070071810A1 (en) *	2003-08-26	2007-03-29	Kenichi Kudo	Additive for tablets
EA200600598A1 (ru)	2003-09-19	2006-08-25	Пенвест Фармасьютикалз Ко.	Лекарственные формы замедленного высвобождения
BRPI0520734A2 (pt)	2005-12-09	2009-05-26	Sca Hygiene Prod Ab	produto absorvente
RU2519715C2 (ru) *	2008-10-23	2014-06-20	Хенкель Корпорейшн	Фармацевтические гранулы, содержащие модифицированный крахмал, и их терапевтические применения
US20130172411A1 (en) *	2010-03-22	2013-07-04	Cadila Healthcare Limited	Stable pharmaceutical compositions comprising fesoterodine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3493652A (en) *	1962-09-14	1970-02-03	Charles W Hartman	Controlled release medicament
GB1072795A (en) *	1963-08-28	1967-06-21	Eastman Kodak Co	Solid composition containing fat-soluble vitamins and processes for making it
US3490742A (en) *	1966-01-14	1970-01-20	Staley Mfg Co A E	Compressed tablets
EP0169893A4 (de) *	1984-01-31	1987-01-22	Scm Corp	Einkapselmatrizenzusammensetzung und diese enthaltendes eingekapseltes erzeugnis.
IT1191674B (it) *	1986-03-07	1988-03-23	Eurand Spa	Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
JPH0747539B2 (ja) *	1986-10-22	1995-05-24	東京田辺製薬株式会社	胆汁酸固形製剤
DE3721574A1 (de) *	1987-06-30	1989-01-12	Kettelhack Riker Pharma Gmbh	Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
GB8812490D0 (en) *	1988-05-26	1988-06-29	Agricultural & Food Res	Delayed release formulations
CA2041774C (en) *	1990-11-27	1994-04-19	Mircea A. Mateescu	Use of cross-linked amylose as a matrix for the slow release of biologically active compounds

1992
- 1992-07-03 NL NL9201195A patent/NL9201195A/nl not_active Application Discontinuation
1993
- 1993-07-02 DE DE69305346T patent/DE69305346T2/de not_active Expired - Fee Related
- 1993-07-02 CA CA002139494A patent/CA2139494A1/en not_active Abandoned
- 1993-07-02 WO PCT/NL1993/000140 patent/WO1994001092A1/en not_active Ceased
- 1993-07-02 US US08/356,256 patent/US5585114A/en not_active Expired - Fee Related
- 1993-07-02 DK DK93916292.1T patent/DK0648116T3/da active
- 1993-07-02 AT AT93916292T patent/ATE143801T1/de not_active IP Right Cessation
- 1993-07-02 EP EP93916292A patent/EP0648116B1/de not_active Expired - Lifetime
- 1993-07-02 JP JP6503185A patent/JPH07508533A/ja active Pending
- 1993-07-02 AU AU45893/93A patent/AU678166B2/en not_active Ceased
- 1993-07-02 ES ES93916292T patent/ES2095658T3/es not_active Expired - Lifetime
1996
- 1996-12-30 GR GR960403674T patent/GR3022195T3/el unknown

Also Published As

Publication number	Publication date
NL9201195A (nl)	1994-02-01
JPH07508533A (ja)	1995-09-21
CA2139494A1 (en)	1994-01-20
WO1994001092A1 (en)	1994-01-20
DE69305346D1 (de)	1996-11-14
AU678166B2 (en)	1997-05-22
DK0648116T3 (da)	1997-03-24
US5585114A (en)	1996-12-17
EP0648116B1 (de)	1996-10-09
GR3022195T3 (en)	1997-03-31
AU4589393A (en)	1994-01-31
DE69305346T2 (de)	1997-04-30
EP0648116A1 (de)	1995-04-19
ES2095658T3 (es)	1997-02-16

Similar Documents

Publication	Publication Date	Title
DE69305346D1 (de)	1996-11-14	Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben
Zhang et al.	2002	Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release
CA2215377A1 (en)	1996-09-26	Controlled delivery compositions and processes for treating organisms in the environment
WO2008025840A2 (de)	2008-03-06	Strukturierte beschichtungen für implantate sowie verfahren zu deren herstellung
EP0402031A3 (de)	1991-03-20	Injizierbare polymere Körper
US6051560A (en)	2000-04-18	Chrondroitin sulfate/sodium hyaluronate composition
ATE152630T1 (de)	1997-05-15	Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
UA27698C2 (uk)	2000-10-16	Спосіб одержання мікрокапсули поліпептиду
ATE179886T1 (de)	1999-05-15	Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung
ES8801687A1 (es)	1988-02-16	Un procedimiento para la preparacion de un polisilaxano macromero con grupos polimerizables no saturados.
EP0627899A4 (de)	1996-11-13	Injektierbare, keramische verbindungen sowie verfahren zur deren herstellung und anwendung.
DE69311404T2 (de)	1997-11-06	Bindemittel und seine Verwendungen
CA2423783A1 (en)	2002-04-04	Inhibition of systemic infections in humans and vertebrates by dietary fibers
KR100193014B1 (en)	1999-06-15	A moisture-curing one-component polysiloxane composition
ATE145821T1 (de)	1996-12-15	Zusammenfassung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselbe
FI956330A0 (fi)	1995-12-29	Polyamidipohjainen jauhekoostumus metallialustojen pinnoitusta varten
DK0722477T3 (da)	1998-01-12	Vandige polymerisatfremstillinger
ATE246515T1 (de)	2003-08-15	Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
HUT58263A (en)	1992-02-28	Galacto-mannane derivatives for coating and incorporating pharmaceutical active components
MX9709614A (es)	1998-07-31	Composiciones emulsificadas de 1-4-bis(bromoacetoxi)-2-buteno utiles como un microbicida y conservador.
MY107183A (en)	1995-09-30	Pharmaceutical compositions
JPS6468316A (en)	1989-03-14	External plaster containing salbutamol
ATE156842T1 (de)	1997-08-15	Oligosaccharide mit biologischer aktivität und verfahren zur herstellung aus glykosaminoglykanen
Uda et al.	2006	Experimental studies on hydroxyapatite powder-carboxymethyl chitin composite: injectable material for bone augmentation
CA2070803A1 (fr)	1992-04-27	Materiau implantable biodegradable et procede de fabrication

Legal Events

Date	Code	Title	Description
1997-05-15	UEP	Publication of translation of european patent specification
2003-04-15	REN	Ceased due to non-payment of the annual fee